Title: Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated Botulinum Toxin-A treatment in children with Cerebral Palsy?
Other Titles: Instrumented measurement of the effect of BTX
Authors: Bar-On, Lynn * ×
Van Campenhout, Anja *
Desloovere, Kaat
Aertbeliën, Erwin
Huenaerts, Catherine
Vandendoorent, Britt
Nieuwenhuys, Angela
Molenaers, Guy #
Issue Date: Mar-2014
Publisher: W.B. Saunders Co.
Series Title: Archives of Physical Medicine and Rehabilitation vol:95 issue:3 pages:515-523
Abstract: Objectives:
To compare (a) responsiveness and (b) predictive ability of clinical and instrumented spasticity assessments after Botulinum-Toxin-A (BTX) treatment combined with casting in the medial hamstrings (MEH) in children with spastic cerebral palsy (CP).

Prospective cohort study

University Hospital

31 children (40 MEH muscles) with CP, consecutive sample, requiring BTX injections.

Clinical and instrumented and spasticity assessments before and 53±14 days after BTX.

Main outcome measures:
Clinical spasticity scales included the Modified Ashworth Scale and the Modified Tardieu Scale. The instrumented spasticity assessment integrated biomechanical (position and torque) and electrophysiological (surface electromyography-sEMG) signals during manually-performed low- and high-velocity passive stretches of the MEH. Signals were compared between both stretch velocities and examined pre- and post-BTX. Responsiveness of clinical and instrumented assessments was compared by percentage exact agreement. Prediction ability was assessed with a logistic regression and the area under the Receiver Operating Characteristic (ROC) curves of the baseline parameters of responders versus non-responders.

Both clinical and instrumented parameters improved post-BTX (p≤0.005), though showed a low percentage exact agreement. The baseline Modified Tardieu Scale was the only clinical scale predictive for response (area under ROC curve=0.7). For the instrumented assessment, baseline values of root mean square (RMS) EMG and of torque were better predictors for a positive response (area under ROC curve=0.82). RMS-EMG remained an important predictor in the logistic regression.

The instrumented spasticity assessment showed higher responsiveness than the clinical scales. The amount of RMS-EMG is considered a promising parameter to predict treatment response.
ISSN: 0003-9993
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Research Group for Neuromotor Rehabilitation
Organ Systems (+)
Production Engineering, Machine Design and Automation (PMA) Section
* (joint) first author
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Bar-On_2014_Archives_accpted.pdfAccepted version of article - not proofed Accepted 211KbAdobe PDFView/Open
Is an instrumented spasticity assessment an improvement over clinical spasticity scales in assessing and predicting the response to integrated botulinum toxin.pdf Published 344KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science